Table 1.

Sociodemographic and clinical characteristics of respondents and nonrespondents.

Characteristics		Respondents (n=45)	Nonrespondents (n=19)	P value, respondents vs nonrespondents
Sex, n (%)				.27
	Male	26 (58)	14 (74)
	Female	19 (42)	5 (26)
Age in years, mean (SD)		60.7 (13.6)	63.8 (14.7)	.28
	<65, n (%)	26 (58)	8 (42)
	≥65, n (%)	19 (42)	11 (58)
Marital status, n (%)
	Partner	34 (76)	N/Aa
	No partner	11 (24)	N/A
Educational level attained, n (%)
	Secondary	8 (18)	N/A
	Intermediate vocational	17 (38)	N/A
	High vocational or university	20 (44)	N/A
Type of lymphoma, n (%)				.26
	Hodgkin	8 (18)	1 (5)
	Non-Hodgkin	37 (82)	18 (95)
Years since diagnosis at time of questionnaire completion, mean (SD)		2.8 (0.8)	2.6 (0.7)	.84
Cancer stage at diagnosis, n (%)				.50
	I	8 (22)	4 (29)
	II	10 (28)	2 (14)
	III	5 (14)	4 (29)
	IV	13 (36)	4 (29)
Primary treatment, n (%)				.11
	Radiotherapy only	2 (4)	1 (5)
	Systemic therapy (eg, chemotherapy, immunotherapy)	19 (42)	8 (42)
	Systemic therapy plus radiotherapy	13 (29)	1 (5)
	Active surveillance	11 (25)	9 (47)
Self-reported comorbidities, mean (SD)		1.3 (1.3)	N/A
Most frequently reported self-reported comorbidities, n (%)
	Arthritis	10 (22)	N/A
	Heart problems	8 (18)	N/A
	High blood pressure	8 (18)	N/A

^aN/A: not available.